These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 27645612)

  • 21. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation.
    Kato Y; Hayashi T; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1490-1496. PubMed ID: 29398536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study.
    Gao Q; Fu X; Wei JW; Chen X; Huang Y; Wang J; Anderson CS; Wong KS;
    Int J Stroke; 2013 Apr; 8(3):150-4. PubMed ID: 22168348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.
    Min J; Farooq MU
    Postgrad Med; 2016 Aug; 128(6):620-8. PubMed ID: 27263867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical inpatients with atrial fibrillation.
    Bo M; Sciarrillo I; Maggiani G; Falcone Y; Iacovino M; Grisoglio E; Fonte G; Grosjean S; Gaita F
    Geriatr Gerontol Int; 2017 Mar; 17(3):416-423. PubMed ID: 26818463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].
    Helms TM; Silber S; Schäfer A; Masuhr F; Palm F; Darius H; Schrör K; Bänsch D; Bramlage P; Hankowitz J; Karle CA; Stargardt T; Weil J; Geller JC
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):295-306. PubMed ID: 27576696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation.
    Djukic M; Braun LM; Unkel S; Jacobshagen C; Nau R
    Drugs Aging; 2018 Sep; 35(9):859-869. PubMed ID: 30066299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
    Chang SS; Dong JZ; Ma CS; Du X; Wu JH; Tang RB; Xia SJ; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Liu XH; Pan JH; Lip GY
    Stroke; 2016 Jul; 47(7):1803-10. PubMed ID: 27283198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA Study.
    Kocabaş U; Ergin I; Yavuz V; Murat S; Özdemir I; Genç Ö; Altın C; Tüner H; Keskin Meriç B; Çoner A; İlkay Yüce E; Boyraz B; Aslan O; Dal A; Şen T; İbişoğlu E; Erdoğan A; Özgeyik M; Demir M; Bilgel ZG; Güvendi Şengör B; Urgun ÖD; Doğduş M; Naki Tekin DD; Çakal S; Çayırlı S; Güler A; Karabulut D; Dalgıç O; Uzman O; Murat B; Şahin Ş; Karabulut U; Kıvrak T; Coşgun MS; Özyurtlu F; Kaplan M; Özçalık E
    Turk Kardiyol Dern Ars; 2023 Mar; 51(2):88-96. PubMed ID: 36916815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study.
    Blacher J; Sorbets E; Guedj Meynier D; Huberman JP; Gauthier J; Cohen S; Hoffman O
    Clin Drug Investig; 2019 Sep; 39(9):891-898. PubMed ID: 31183629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underuse of anticoagulation in patients with atrial fibrillation.
    Vallakati A; Lewis WR
    Postgrad Med; 2016; 128(2):191-200. PubMed ID: 26666288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.
    Steinberg BA; Gao H; Shrader P; Pieper K; Thomas L; Camm AJ; Ezekowitz MD; Fonarow GC; Gersh BJ; Goldhaber S; Haas S; Hacke W; Kowey PR; Ansell J; Mahaffey KW; Naccarelli G; Reiffel JA; Turpie A; Verheugt F; Piccini JP; Kakkar A; Peterson ED; Fox KAA; ;
    Am Heart J; 2017 Dec; 194():132-140. PubMed ID: 29223431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is it necessary to prescribe oral anticoagulant therapy for paroxysmal atrial fibrillation during acute coronary syndrome, and for how long?].
    Visconti LO; Ferlini M; Rordorf R; Savastano S
    G Ital Cardiol (Rome); 2019 Jun; 20(6):361-366. PubMed ID: 31184322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underuse of Oral Anticoagulants in Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Guo J; Guan T; Fan S; Chao B; Wang L; Liu Y
    Am J Cardiol; 2018 Dec; 122(12):2055-2061. PubMed ID: 30292336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Paciaroni M; Agnelli G; Caso V; Silvestrelli G; Seiffge DJ; Engelter S; De Marchis GM; Polymeris A; Zedde ML; Yaghi S; Michel P; Eskandari A; Antonenko K; Sohn SI; Cappellari M; Tassinari T; Tassi R; Masotti L; Katsanos AH; Giannopoulos S; Acciarresi M; Alberti A; Venti M; Mosconi MG; Vedovati MC; Pierini P; Giustozzi M; Lotti EM; Ntaios G; Kargiotis O; Monaco S; Lochner P; Bandini F; Liantinioti C; Palaiodimou L; Abdul-Rahim AH; Lees K; Mancuso M; Pantoni L; Rosa S; Bertora P; Galliazzo S; Ageno W; Toso E; Angelini F; Chiti A; Orlandi G; Denti L; Flomin Y; Marcheselli S; Mumoli N; Rimoldi A; Verrengia E; Schirinzi E; Del Sette M; Papamichalis P; Komnos A; Popovic N; Zarkov M; Rocco A; Diomedi M; Giorli E; Ciccone A; Mac Grory BC; Furie KL; Bonetti B; Saia V; Guideri F; Acampa M; Martini G; Grifoni E; Padroni M; Karagkiozi E; Perlepe K; Makaritsis K; Mannino M; Maccarrone M; Ulivi L; Giannini N; Ferrari E; Pezzini A; Doronin B; Volodina V; Baldi A; D'Amore C; Deleu D; Corea F; Putaala J; Santalucia P; Nardi K; Risitano A; Toni D; Tsivgoulis G
    Stroke; 2019 Aug; 50(8):2168-2174. PubMed ID: 31234756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.
    Lauffenburger JC; Farley JF; Gehi AK; Rhoney DH; Brookhart MA; Fang G
    Am J Cardiol; 2015 Apr; 115(8):1095-101. PubMed ID: 25724781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.